Jazz Pharmaceuticals plc — Director's Dealing 2021

Sep 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2021-09-08

Reporting Person: Larkin Finbar (SVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-08	Ordinary Shares	S	63	$134.51	Disposed	16579	Direct

Footnotes

F1: Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price and required withholding taxes.

F2: Includes 86 ordinary shares, share quantity adjusted for rounding, purchased on March 15, 2021 by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme in transactions exempt under Rule 16b-3(c).

Also includes 123 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021.